Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID O14746 7015 TERT EST2 TCS1 TRT Idiopathic fibrosing alveolitis Phosphorylation C S227 O14746 7015 TERT EST2 TCS1 TRT Pancreatic adenocarcinoma Phosphorylation C S227 O14746 7015 TERT EST2 TCS1 TRT Idiopathic fibrosing alveolitis Phosphorylation N S227 O14746 7015 TERT EST2 TCS1 TRT Lung cancer Ubiquitination N K236 O14746 7015 TERT EST2 TCS1 TRT Brain lower grade glioma Phosphorylation N T249 O14746 7015 TERT EST2 TCS1 TRT Head and neck squamous cell carcinoma Phosphorylation N T249 O14746 7015 TERT EST2 TCS1 TRT Idiopathic fibrosing alveolitis Phosphorylation N T249 O14746 7015 TERT EST2 TCS1 TRT Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S349 O14746 7015 TERT EST2 TCS1 TRT Idiopathic fibrosing alveolitis Phosphorylation N S349 O14746 7015 TERT EST2 TCS1 TRT Idiopathic fibrosing alveolitis Phosphorylation N S457 O14746 7015 TERT EST2 TCS1 TRT Inherited immunodeficiency diseases Phosphorylation N S457 O14746 7015 TERT EST2 TCS1 TRT Melanoma Phosphorylation N S457 O14746 7015 TERT EST2 TCS1 TRT Aplastic anemia Phosphorylation N S679 O14746 7015 TERT EST2 TCS1 TRT Dyskeratosis congenita Phosphorylation N S679 O14746 7015 TERT EST2 TCS1 TRT Idiopathic fibrosing alveolitis Phosphorylation N S679 O14746 7015 TERT EST2 TCS1 TRT Uterine corpus endometrial carcinoma Phosphorylation N S679 O14746 7015 TERT EST2 TCS1 TRT Aplastic anemia Phosphorylation N T692 O14746 7015 TERT EST2 TCS1 TRT Dyskeratosis congenita Phosphorylation N T692 O14746 7015 TERT EST2 TCS1 TRT Idiopathic fibrosing alveolitis Phosphorylation N T692 O14746 7015 TERT EST2 TCS1 TRT Lung cancer Phosphorylation N T692 O14746 7015 TERT EST2 TCS1 TRT Sarcoma Phosphorylation N T692 O14746 7015 TERT EST2 TCS1 TRT Breast adenocarcinoma Phosphorylation N Y707 O14746 7015 TERT EST2 TCS1 TRT Dyskeratosis congenita Phosphorylation N Y707 O14746 7015 TERT EST2 TCS1 TRT Idiopathic fibrosing alveolitis Phosphorylation N Y707 O14746 7015 TERT EST2 TCS1 TRT Pulmonary fibrosis Phosphorylation N T767 O14746 7015 TERT EST2 TCS1 TRT Idiopathic fibrosing alveolitis Phosphorylation C S797 O14746 7015 TERT EST2 TCS1 TRT Idiopathic fibrosing alveolitis Phosphorylation N S797 O14746 7015 TERT EST2 TCS1 TRT Skin cutaneous melanoma Phosphorylation N S797 O14746 7015 TERT EST2 TCS1 TRT Idiopathic fibrosing alveolitis Phosphorylation N S824 O14746 7015 TERT EST2 TCS1 TRT Dyskeratosis congenita Phosphorylation N S984 O14746 7015 TERT EST2 TCS1 TRT Adrenocortical carcinoma Phosphorylation N T1113 O14746 7015 TERT EST2 TCS1 TRT Dyskeratosis congenita Phosphorylation N T1113 O14746 7015 TERT EST2 TCS1 TRT Idiopathic fibrosing alveolitis Phosphorylation N T1113 O14746 7015 TERT EST2 TCS1 TRT Pulmonary fibrosis Phosphorylation N T1113 O14746 7015 TERT EST2 TCS1 TRT Rectum adenocarcinoma Phosphorylation N T1113 O14746 7015 TERT EST2 TCS1 TRT Adrenocortical carcinoma Phosphorylation N S1125 O14746 7015 TERT EST2 TCS1 TRT Dyskeratosis congenita Phosphorylation N S1125 O14746 7015 TERT EST2 TCS1 TRT Idiopathic fibrosing alveolitis Phosphorylation N S1125 O14746 7015 TERT EST2 TCS1 TRT Pancreatic adenocarcinoma Phosphorylation N S1125 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Acetylation N A2 O60832 1736 DKC1 NOLA4 Hepatocellular carcinoma Acetylation N A2 O60832 1736 DKC1 NOLA4 Breast invasive carcinoma Ubiquitination N K20 O60832 1736 DKC1 NOLA4 Colon adenocarcinoma Ubiquitination N K20 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K20 O60832 1736 DKC1 NOLA4 Breast invasive carcinoma Phosphorylation N S21 O60832 1736 DKC1 NOLA4 Colon adenocarcinoma Phosphorylation N S21 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Phosphorylation N S21 O60832 1736 DKC1 NOLA4 Lung adenocarcinoma Phosphorylation N S21 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Acetylation N K39 O60832 1736 DKC1 NOLA4 Global developmental delay Acetylation N K39 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita SUMOylation N K39 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita SUMOylation N K39 O60832 1736 DKC1 NOLA4 Global developmental delay SUMOylation N K39 O60832 1736 DKC1 NOLA4 Hoyeraal-Hreidarsson syndrome SUMOylation N K39 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K39 O60832 1736 DKC1 NOLA4 Global developmental delay Ubiquitination N K39 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita SUMOylation N K43 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita SUMOylation N K43 O60832 1736 DKC1 NOLA4 Global developmental delay SUMOylation N K43 O60832 1736 DKC1 NOLA4 Hoyeraal-Hreidarsson syndrome SUMOylation N K43 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K43 O60832 1736 DKC1 NOLA4 Global developmental delay Ubiquitination N K43 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Acetylation N K46 O60832 1736 DKC1 NOLA4 Hoyeraal-Hreidarsson syndrome Acetylation N K46 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K46 O60832 1736 DKC1 NOLA4 Global developmental delay Ubiquitination N K46 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K57 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K57 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Acetylation N K61 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K61 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K80 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K117 O60832 1736 DKC1 NOLA4 Head and neck squamous cell carcinoma Ubiquitination N K117 O60832 1736 DKC1 NOLA4 Hoyeraal-Hreidarsson syndrome Ubiquitination N K117 O60832 1736 DKC1 NOLA4 Hoyeraal-Hreidarsson syndrome Phosphorylation N T118 O60832 1736 DKC1 NOLA4 Hoyeraal-Hreidarsson syndrome Phosphorylation N S121 O60832 1736 DKC1 NOLA4 Hoyeraal-Hreidarsson syndrome Phosphorylation N T123 O60832 1736 DKC1 NOLA4 Bladder urothelial carcinoma Ubiquitination N K151 O60832 1736 DKC1 NOLA4 Bladder urothelial carcinoma Phosphorylation N Y153 O60832 1736 DKC1 NOLA4 CHINE1 Ubiquitination N K203 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K203 O60832 1736 DKC1 NOLA4 Skin cutaneous melanoma Ubiquitination N K203 O60832 1736 DKC1 NOLA4 Stomach adenocarcinoma Ubiquitination N K203 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K257 O60832 1736 DKC1 NOLA4 Lung adenocarcinoma Ubiquitination N K257 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Acetylation N K277 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Phosphorylation N Y287 O60832 1736 DKC1 NOLA4 Lung adenocarcinoma Phosphorylation N Y287 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K297 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K302 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K379 O60832 1736 DKC1 NOLA4 Glioblastoma multiforme Ubiquitination N K379 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K385 O60832 1736 DKC1 NOLA4 Glioblastoma multiforme Ubiquitination N K385 O60832 1736 DKC1 NOLA4 Glioblastoma multiforme Phosphorylation N S387 O60832 1736 DKC1 NOLA4 Liver cancer Phosphorylation N S387 O60832 1736 DKC1 NOLA4 Stomach adenocarcinoma Phosphorylation N S387 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita SUMOylation N K394 O60832 1736 DKC1 NOLA4 Stomach adenocarcinoma SUMOylation N K394 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K394 O60832 1736 DKC1 NOLA4 Stomach adenocarcinoma Ubiquitination N K394 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K403 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K403 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita SUMOylation N K413 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita SUMOylation N K413 O60832 1736 DKC1 NOLA4 Stomach adenocarcinoma SUMOylation N K413 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K413 O60832 1736 DKC1 NOLA4 Stomach adenocarcinoma Ubiquitination N K413 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Phosphorylation N Y416 O60832 1736 DKC1 NOLA4 Stomach adenocarcinoma Phosphorylation N Y416 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Phosphorylation N Y419 O60832 1736 DKC1 NOLA4 Skin cutaneous melanoma Phosphorylation N Y419 O60832 1736 DKC1 NOLA4 Stomach adenocarcinoma Phosphorylation N Y419 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Phosphorylation N S422 O60832 1736 DKC1 NOLA4 Skin cutaneous melanoma Phosphorylation N S422 O60832 1736 DKC1 NOLA4 Stomach adenocarcinoma Phosphorylation N S422 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K425 O60832 1736 DKC1 NOLA4 Skin cutaneous melanoma Ubiquitination N K425 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Ubiquitination N K433 O60832 1736 DKC1 NOLA4 Skin cutaneous melanoma Ubiquitination N K433 O60832 1736 DKC1 NOLA4 Adrenocortical carcinoma Phosphorylation N S451 O60832 1736 DKC1 NOLA4 Breast invasive carcinoma Phosphorylation N S451 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Phosphorylation N S451 O60832 1736 DKC1 NOLA4 Inherited immunodeficiency diseases Phosphorylation N S451 O60832 1736 DKC1 NOLA4 Uterine cancer Phosphorylation N S451 O60832 1736 DKC1 NOLA4 Adrenocortical carcinoma Phosphorylation N S453 O60832 1736 DKC1 NOLA4 Breast invasive carcinoma Phosphorylation N S453 O60832 1736 DKC1 NOLA4 Cervical squamous cell carcinoma Phosphorylation N S453 O60832 1736 DKC1 NOLA4 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S453 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Phosphorylation N S453 O60832 1736 DKC1 NOLA4 Inherited immunodeficiency diseases Phosphorylation N S453 O60832 1736 DKC1 NOLA4 Breast invasive carcinoma Phosphorylation N S455 O60832 1736 DKC1 NOLA4 Cervical squamous cell carcinoma Phosphorylation N S455 O60832 1736 DKC1 NOLA4 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S455 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Phosphorylation N S455 O60832 1736 DKC1 NOLA4 Inherited immunodeficiency diseases Phosphorylation N S455 O60832 1736 DKC1 NOLA4 Breast invasive carcinoma Phosphorylation N T458 O60832 1736 DKC1 NOLA4 Cervical squamous cell carcinoma Phosphorylation N T458 O60832 1736 DKC1 NOLA4 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N T458 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Phosphorylation N T458 O60832 1736 DKC1 NOLA4 Colorectal cancer Phosphorylation N S485 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Phosphorylation N S485 O60832 1736 DKC1 NOLA4 Glioblastoma multiforme Phosphorylation N S485 O60832 1736 DKC1 NOLA4 Renal cell carcinoma Phosphorylation N S485 O60832 1736 DKC1 NOLA4 Glioblastoma multiforme Phosphorylation N S494 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Phosphorylation N T497 O60832 1736 DKC1 NOLA4 Dyskeratosis congenita Phosphorylation N S513 O60832 1736 DKC1 NOLA4 Malignant glioma Phosphorylation N S513 O60832 1736 DKC1 NOLA4 Skin cutaneous melanoma Phosphorylation N S513 P15391 930 CD19 Inherited immunodeficiency diseases N-linked glycosylation N N86 P15391 930 CD19 Lung adenocarcinoma N-linked glycosylation N N86 P15391 930 CD19 Bladder urothelial carcinoma Phosphorylation N Y378 P15391 930 CD19 Breast invasive carcinoma Phosphorylation N Y378 P15391 930 CD19 Glioblastoma Phosphorylation N Y378 P15391 930 CD19 Bladder urothelial carcinoma Phosphorylation N S497 P15391 930 CD19 Skin cutaneous melanoma Phosphorylation N S497 P15391 930 CD19 Bladder urothelial carcinoma Phosphorylation N S499 P15391 930 CD19 Skin cutaneous melanoma Phosphorylation N S499 P15391 930 CD19 Bladder urothelial carcinoma Phosphorylation N Y500 P15391 930 CD19 Lung cancer Phosphorylation N Y500 P15391 930 CD19 Skin cutaneous melanoma Phosphorylation N Y500 P15391 930 CD19 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N Y508 P15391 930 CD19 Colon adenocarcinoma Phosphorylation N Y508 P15391 930 CD19 Skin cutaneous melanoma Phosphorylation N Y508 P15391 930 CD19 Uterine corpus endometrial carcinoma Phosphorylation N Y508 P15391 930 CD19 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S515 P15391 930 CD19 Colon adenocarcinoma Phosphorylation N S515 P15391 930 CD19 Uterine corpus endometrial carcinoma Phosphorylation N S515 P15391 930 CD19 Bladder urothelial carcinoma Phosphorylation N S530 P15391 930 CD19 Renal cell carcinoma Phosphorylation N S530 P15391 930 CD19 Transitional cell carcinoma Phosphorylation N S530 P15391 930 CD19 Bladder urothelial carcinoma Phosphorylation N Y531 P15391 930 CD19 Renal cell carcinoma Phosphorylation N Y531 P15391 930 CD19 Transitional cell carcinoma Phosphorylation N Y531 P40763 6774 STAT3 APRF Colorectal adenocarcinoma Phosphorylation N Y45 P40763 6774 STAT3 APRF Colorectal adenocarcinoma Acetylation N K49 P40763 6774 STAT3 APRF Colorectal adenocarcinoma Methylation N K49 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Acetylation N K87 P40763 6774 STAT3 APRF Skin cutaneous melanoma Acetylation N K87 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K87 P40763 6774 STAT3 APRF Skin cutaneous melanoma Ubiquitination N K87 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K97 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K153 P40763 6774 STAT3 APRF Lung adenocarcinoma Ubiquitination N K153 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K161 P40763 6774 STAT3 APRF Lung adenocarcinoma Ubiquitination N K161 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K163 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma SUMOylation N K177 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome SUMOylation N K177 P40763 6774 STAT3 APRF Lung adenocarcinoma SUMOylation N K177 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Ubiquitination N K177 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K177 P40763 6774 STAT3 APRF Lung adenocarcinoma Ubiquitination N K177 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Ubiquitination N K180 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K180 P40763 6774 STAT3 APRF Lung adenocarcinoma Ubiquitination N K180 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K199 P40763 6774 STAT3 APRF Lung squamous cell carcinoma Ubiquitination N K199 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Ubiquitination N K283 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K283 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Ubiquitination N K283 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K290 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Ubiquitination N K290 P40763 6774 STAT3 APRF Kidney renal clear cell carcinoma Ubiquitination N K290 P40763 6774 STAT3 APRF Prostate adenocarcinoma Ubiquitination N K290 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Ubiquitination N K294 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K294 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Ubiquitination N K294 P40763 6774 STAT3 APRF Kidney renal clear cell carcinoma Ubiquitination N K294 P40763 6774 STAT3 APRF Prostate adenocarcinoma Ubiquitination N K294 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K318 P40763 6774 STAT3 APRF Skin cutaneous melanoma Ubiquitination N K318 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K348 P40763 6774 STAT3 APRF Uterine corpus endometrial carcinoma Ubiquitination N K348 P40763 6774 STAT3 APRF Skin cutaneous melanoma Ubiquitination N K363 P40763 6774 STAT3 APRF Uterine corpus endometrial carcinoma Ubiquitination N K363 P40763 6774 STAT3 APRF Uterine corpus endometrial carcinoma Ubiquitination N K365 P40763 6774 STAT3 APRF Kidney renal papillary cell carcinoma Acetylation N K370 P40763 6774 STAT3 APRF Uterine corpus endometrial carcinoma Acetylation N K370 P40763 6774 STAT3 APRF Kidney renal papillary cell carcinoma Ubiquitination N K370 P40763 6774 STAT3 APRF Uterine corpus endometrial carcinoma Ubiquitination N K370 P40763 6774 STAT3 APRF hyper IgE syndrome Acetylation N K383 P40763 6774 STAT3 APRF Breast invasive carcinoma Ubiquitination N K383 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K383 P40763 6774 STAT3 APRF Uterine carcinosarcoma Ubiquitination N K383 P40763 6774 STAT3 APRF Bladder urothelial carcinoma Ubiquitination N K409 P40763 6774 STAT3 APRF Breast invasive carcinoma Ubiquitination N K409 P40763 6774 STAT3 APRF Hepatocellular carcinoma Ubiquitination N K409 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K409 P40763 6774 STAT3 APRF Bladder urothelial carcinoma Phosphorylation N S429 P40763 6774 STAT3 APRF Breast invasive carcinoma Phosphorylation N S429 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N S429 P40763 6774 STAT3 APRF Lung adenocarcinoma Phosphorylation N S429 P40763 6774 STAT3 APRF hyper IgE syndrome Phosphorylation N S429 P40763 6774 STAT3 APRF Bladder urothelial carcinoma Phosphorylation N T440 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N T440 P40763 6774 STAT3 APRF Pheochromocytoma and Paraganglioma Phosphorylation N T440 P40763 6774 STAT3 APRF hyper IgE syndrome Phosphorylation N T440 P40763 6774 STAT3 APRF Bladder urothelial carcinoma Phosphorylation N Y446 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N Y446 P40763 6774 STAT3 APRF Pheochromocytoma and Paraganglioma Phosphorylation N Y446 P40763 6774 STAT3 APRF Bladder urothelial carcinoma SUMOylation N K451 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome SUMOylation N K451 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome SUMOylation N K495 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N Y539 P40763 6774 STAT3 APRF Ovarian serous cystadenocarcinoma Phosphorylation N Y539 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K551 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Ubiquitination N K574 P40763 6774 STAT3 APRF Uterine corpus endometrial carcinoma Ubiquitination N K574 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Acetylation N K601 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K601 P40763 6774 STAT3 APRF Breast invasive carcinoma Acetylation N K615 P40763 6774 STAT3 APRF Cervical squamous cell carcinoma and endocervical adenocarcinoma Acetylation N K615 P40763 6774 STAT3 APRF Hematologic cancer Acetylation N K615 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Acetylation N K615 P40763 6774 STAT3 APRF Lung squamous cell carcinoma Acetylation N K615 P40763 6774 STAT3 APRF Lymphoid neoplasm diffuse large B-cell lymphoma Acetylation N K615 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Acetylation N K615 P40763 6774 STAT3 APRF Prostate adenocarcinoma Acetylation N K615 P40763 6774 STAT3 APRF Breast invasive carcinoma Ubiquitination N K615 P40763 6774 STAT3 APRF Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K615 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K615 P40763 6774 STAT3 APRF Lung squamous cell carcinoma Ubiquitination N K615 P40763 6774 STAT3 APRF Lymphoid neoplasm diffuse large B-cell lymphoma Ubiquitination N K615 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Ubiquitination N K615 P40763 6774 STAT3 APRF Prostate adenocarcinoma Ubiquitination N K615 P40763 6774 STAT3 APRF hyper IgE syndrome Ubiquitination N K615 P40763 6774 STAT3 APRF hyper IgE syndrome Phosphorylation N T622 P40763 6774 STAT3 APRF Breast invasive carcinoma Ubiquitination N K626 P40763 6774 STAT3 APRF hyper IgE syndrome Ubiquitination N K626 P40763 6774 STAT3 APRF Breast invasive carcinoma Acetylation N K631 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Acetylation N K631 P40763 6774 STAT3 APRF Breast invasive carcinoma Ubiquitination N K631 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K631 P40763 6774 STAT3 APRF hyper IgE syndrome Phosphorylation N T632 P40763 6774 STAT3 APRF hyper IgE syndrome Phosphorylation N S636 P40763 6774 STAT3 APRF Breast invasive carcinoma Phosphorylation N Y640 P40763 6774 STAT3 APRF Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N Y640 P40763 6774 STAT3 APRF Glioblastoma multiforme Phosphorylation N Y640 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Phosphorylation N Y640 P40763 6774 STAT3 APRF Hepatocellular carcinoma Phosphorylation N Y640 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N Y640 P40763 6774 STAT3 APRF Lymphoid neoplasm diffuse large B-cell lymphoma Phosphorylation N Y640 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Phosphorylation N Y640 P40763 6774 STAT3 APRF Prostate adenocarcinoma Phosphorylation N Y640 P40763 6774 STAT3 APRF hyper IgE syndrome Phosphorylation N Y640 P40763 6774 STAT3 APRF Autoimmune disease, multisystem, infantile-onset Phosphorylation N T641 P40763 6774 STAT3 APRF hyper IgE syndrome Phosphorylation N T641 P40763 6774 STAT3 APRF Autoimmune disease, multisystem, infantile-onset Ubiquitination N K642 P40763 6774 STAT3 APRF Breast invasive carcinoma Ubiquitination N K642 P40763 6774 STAT3 APRF Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K642 P40763 6774 STAT3 APRF Glioblastoma multiforme Ubiquitination N K642 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Ubiquitination N K642 P40763 6774 STAT3 APRF Hepatocellular carcinoma Ubiquitination N K642 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K642 P40763 6774 STAT3 APRF Lymphoid neoplasm diffuse large B-cell lymphoma Ubiquitination N K642 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Ubiquitination N K642 P40763 6774 STAT3 APRF Prostate adenocarcinoma Ubiquitination N K642 P40763 6774 STAT3 APRF hyper IgE syndrome Ubiquitination N K642 P40763 6774 STAT3 APRF Breast adenocarcinoma Phosphorylation N Y657 P40763 6774 STAT3 APRF Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N Y657 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Phosphorylation N Y657 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N Y657 P40763 6774 STAT3 APRF Lymphoid neoplasm diffuse large B-cell lymphoma Phosphorylation N Y657 P40763 6774 STAT3 APRF Stomach adenocarcinoma Phosphorylation N Y657 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N Y674 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Phosphorylation N Y674 P40763 6774 STAT3 APRF Prostate adenocarcinoma Phosphorylation N Y674 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K679 P40763 6774 STAT3 APRF Hepatocellular carcinoma Acetylation N K685 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Acetylation N K685 P40763 6774 STAT3 APRF Hepatocellular carcinoma Ubiquitination N K685 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K685 P40763 6774 STAT3 APRF Hepatocellular carcinoma Phosphorylation N Y686 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N Y686 P40763 6774 STAT3 APRF Hepatocellular carcinoma Phosphorylation N S691 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N S691 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N S701 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Phosphorylation N S701 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N Y705 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Phosphorylation N Y705 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Acetylation N K707 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Acetylation N K707 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K707 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Ubiquitination N K707 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N T708 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Phosphorylation N T708 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation C T714 P40763 6774 STAT3 APRF Autoimmune disease, multisystem, infantile-onset Phosphorylation N T714 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Phosphorylation N T714 P40763 6774 STAT3 APRF Autoimmune disease, multisystem, infantile-onset Phosphorylation N T716 P40763 6774 STAT3 APRF Autoimmune disease, multisystem, infantile-onset Phosphorylation N T717 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N T717 P40763 6774 STAT3 APRF Autoimmune disease, multisystem, infantile-onset Phosphorylation N S719 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N S719 P40763 6774 STAT3 APRF Kidney renal clear cell carcinoma Phosphorylation N S719 P40763 6774 STAT3 APRF Autoimmune disease, multisystem, infantile-onset Phosphorylation N T721 P40763 6774 STAT3 APRF Kidney renal clear cell carcinoma Phosphorylation N T721 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Phosphorylation N T721 P40763 6774 STAT3 APRF Kidney renal clear cell carcinoma Phosphorylation N S727 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Phosphorylation N S727 P42224 6772 STAT1 Immunodeficiency Phosphorylation N S2 P42224 6772 STAT1 Stomach adenocarcinoma Phosphorylation N S2 P42224 6772 STAT1 Hepatocellular carcinoma Methylation N K114 P42224 6772 STAT1 Lung adenocarcinoma Methylation N K114 P42224 6772 STAT1 Lung cancer Methylation N K114 P42224 6772 STAT1 Hepatocellular carcinoma SUMOylation N K114 P42224 6772 STAT1 Lung adenocarcinoma SUMOylation N K114 P42224 6772 STAT1 Hepatocellular carcinoma Ubiquitination N K114 P42224 6772 STAT1 Lung adenocarcinoma Ubiquitination N K114 P42224 6772 STAT1 Chronic lymphocytic leukemia Ubiquitination N K152 P42224 6772 STAT1 Lung adenocarcinoma Ubiquitination N K152 P42224 6772 STAT1 Chronic lymphocytic leukemia Ubiquitination N K161 P42224 6772 STAT1 Hepatocellular carcinoma Ubiquitination N K161 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K161 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K161 P42224 6772 STAT1 Kidney renal clear cell carcinoma Ubiquitination N K161 P42224 6772 STAT1 Lung adenocarcinoma Ubiquitination N K161 P42224 6772 STAT1 Stomach adenocarcinoma Ubiquitination N K161 P42224 6772 STAT1 Chronic lymphocytic leukemia Phosphorylation N S162 P42224 6772 STAT1 Hepatocellular carcinoma Phosphorylation N S162 P42224 6772 STAT1 Immunodeficiency Phosphorylation N S162 P42224 6772 STAT1 Kidney renal clear cell carcinoma Phosphorylation N S162 P42224 6772 STAT1 Stomach adenocarcinoma Phosphorylation N S162 P42224 6772 STAT1 Immunodeficiency Phosphorylation N Y170 P42224 6772 STAT1 Immunodeficiency Acetylation N K173 P42224 6772 STAT1 Hepatocellular carcinoma Ubiquitination N K173 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K173 P42224 6772 STAT1 Stomach adenocarcinoma Ubiquitination N K173 P42224 6772 STAT1 Hepatocellular carcinoma Methylation N K175 P42224 6772 STAT1 Immunodeficiency Methylation N K175 P42224 6772 STAT1 Hepatocellular carcinoma Ubiquitination N K175 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K175 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K175 P42224 6772 STAT1 Immunodeficiency Phosphorylation N T184 P42224 6772 STAT1 Head and neck squamous cell carcinoma SUMOylation N K193 P42224 6772 STAT1 Rectum adenocarcinoma SUMOylation N K193 P42224 6772 STAT1 Head and neck squamous cell carcinoma Ubiquitination N K193 P42224 6772 STAT1 Rectum adenocarcinoma Ubiquitination N K193 P42224 6772 STAT1 Glioblastoma Ubiquitination N K200 P42224 6772 STAT1 Glioblastoma multiforme Ubiquitination N K200 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K200 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K200 P42224 6772 STAT1 Rectum adenocarcinoma Ubiquitination N K200 P42224 6772 STAT1 Glioblastoma Acetylation N K201 P42224 6772 STAT1 Glioblastoma multiforme Acetylation N K201 P42224 6772 STAT1 Immunodeficiency Acetylation N K201 P42224 6772 STAT1 Rectum adenocarcinoma Acetylation N K201 P42224 6772 STAT1 Glioblastoma multiforme Ubiquitination N K201 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K201 P42224 6772 STAT1 Rectum adenocarcinoma Ubiquitination N K201 P42224 6772 STAT1 Glioblastoma Phosphorylation N Y203 P42224 6772 STAT1 Immunodeficiency Phosphorylation N Y203 P42224 6772 STAT1 Esophageal adenocarcinoma Ubiquitination N K240 P42224 6772 STAT1 Uterus adenocarcinoma Ubiquitination N K240 P42224 6772 STAT1 Immunodeficiency Acetylation N K279 P42224 6772 STAT1 Colon adenocarcinoma Ubiquitination N K286 P42224 6772 STAT1 Hepatocellular carcinoma Ubiquitination N K286 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K286 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K286 P42224 6772 STAT1 Inherited immunodeficiency diseases Ubiquitination N K286 P42224 6772 STAT1 Kidney renal papillary cell carcinoma Ubiquitination N K286 P42224 6772 STAT1 Colon adenocarcinoma Methylation N K296 P42224 6772 STAT1 Head and neck squamous cell carcinoma Methylation N K296 P42224 6772 STAT1 Hepatocellular carcinoma Methylation N K296 P42224 6772 STAT1 Colon adenocarcinoma Ubiquitination N K296 P42224 6772 STAT1 Head and neck squamous cell carcinoma Ubiquitination N K296 P42224 6772 STAT1 Hepatocellular carcinoma Ubiquitination N K296 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K296 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K298 P42224 6772 STAT1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K350 P42224 6772 STAT1 Hepatocellular carcinoma Ubiquitination N K359 P42224 6772 STAT1 Hepatocellular carcinoma Ubiquitination N K361 P42224 6772 STAT1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Methylation N K366 P42224 6772 STAT1 Hepatocellular carcinoma Methylation N K366 P42224 6772 STAT1 Lung cancer Methylation N K366 P42224 6772 STAT1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K366 P42224 6772 STAT1 Hepatocellular carcinoma Ubiquitination N K366 P42224 6772 STAT1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N T373 P42224 6772 STAT1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K375 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K379 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K379 P42224 6772 STAT1 Stomach adenocarcinoma Ubiquitination N K379 P42224 6772 STAT1 Immunodeficiency Phosphorylation N T387 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K388 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K388 P42224 6772 STAT1 Skin cutaneous melanoma Ubiquitination N K388 P42224 6772 STAT1 Stomach adenocarcinoma Ubiquitination N K388 P42224 6772 STAT1 Bladder urothelial carcinoma Acetylation N K410 P42224 6772 STAT1 Breast invasive carcinoma Acetylation N K410 P42224 6772 STAT1 Uterine corpus endometrial carcinoma Acetylation N K410 P42224 6772 STAT1 Bladder urothelial carcinoma Ubiquitination N K410 P42224 6772 STAT1 Breast invasive carcinoma Ubiquitination N K410 P42224 6772 STAT1 Uterine corpus endometrial carcinoma Ubiquitination N K410 P42224 6772 STAT1 Breast invasive carcinoma Acetylation N K413 P42224 6772 STAT1 Stomach adenocarcinoma Acetylation N K413 P42224 6772 STAT1 Bladder urothelial carcinoma Ubiquitination N K511 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K511 P42224 6772 STAT1 Uterine corpus endometrial carcinoma Methylation N K525 P42224 6772 STAT1 Uterine corpus endometrial carcinoma Ubiquitination N K525 P42224 6772 STAT1 Sarcoma Phosphorylation N S532 P42224 6772 STAT1 Skin cutaneous melanoma Phosphorylation N S532 P42224 6772 STAT1 Uterine corpus endometrial carcinoma Phosphorylation N S532 P42224 6772 STAT1 Colon adenocarcinoma Ubiquitination N K544 P42224 6772 STAT1 Sarcoma Ubiquitination N K544 P42224 6772 STAT1 Skin cutaneous melanoma Ubiquitination N K544 P42224 6772 STAT1 Skin cutaneous melanoma Phosphorylation N S583 P42224 6772 STAT1 Breast invasive carcinoma Ubiquitination N K592 P42224 6772 STAT1 Lung adenocarcinoma Ubiquitination N K592 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K636 P42224 6772 STAT1 Immunodeficiency Methylation N K637 P42224 6772 STAT1 Lung adenocarcinoma Methylation N K637 P42224 6772 STAT1 Uterine corpus endometrial carcinoma Methylation N K637 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K637 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K637 P42224 6772 STAT1 Lung adenocarcinoma Ubiquitination N K637 P42224 6772 STAT1 Uterine corpus endometrial carcinoma Ubiquitination N K637 P42224 6772 STAT1 Lung adenocarcinoma Phosphorylation C S640 P42224 6772 STAT1 Immunodeficiency Phosphorylation N S640 P42224 6772 STAT1 Lung adenocarcinoma Phosphorylation N S640 P42224 6772 STAT1 Bladder urothelial carcinoma SUMOylation N K652 P42224 6772 STAT1 Hepatocellular carcinoma SUMOylation N K652 P42224 6772 STAT1 Immunodeficiency SUMOylation N K652 P42224 6772 STAT1 Bladder urothelial carcinoma Ubiquitination N K652 P42224 6772 STAT1 Hepatocellular carcinoma Ubiquitination N K652 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K652 P42224 6772 STAT1 Lung cancer ADP-ribosylation N E657 P42224 6772 STAT1 Hepatocellular carcinoma Methylation N K665 P42224 6772 STAT1 Hepatocellular carcinoma Ubiquitination N K665 P42224 6772 STAT1 Hepatocellular carcinoma Phosphorylation N Y668 P42224 6772 STAT1 Immunodeficiency Phosphorylation N Y668 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K673 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K673 P42224 6772 STAT1 Immunodeficiency SUMOylation N K679 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K679 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K697 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K697 P42224 6772 STAT1 Immunodeficiency Phosphorylation N T699 P42224 6772 STAT1 Head and neck squamous cell carcinoma Phosphorylation N Y701 P42224 6772 STAT1 Immunodeficiency Phosphorylation N Y701 P42224 6772 STAT1 Head and neck squamous cell carcinoma SUMOylation N K703 P42224 6772 STAT1 Immunodeficiency SUMOylation N K703 P42224 6772 STAT1 Immunodeficiency SUMOylation N K703 P42224 6772 STAT1 Head and neck squamous cell carcinoma Ubiquitination N K703 P42224 6772 STAT1 Immunodeficiency Ubiquitination N K703 P42224 6772 STAT1 Immunodeficiency Phosphorylation N T704 P42224 6772 STAT1 Head and neck cancer ADP-ribosylation N E705 P42224 6772 STAT1 Urinary bladder cancer ADP-ribosylation N E705 P42224 6772 STAT1 Head and neck squamous cell carcinoma Phosphorylation N S708 P42224 6772 STAT1 Immunodeficiency Phosphorylation N S708 P42224 6772 STAT1 Lung adenocarcinoma Phosphorylation N S708 P42224 6772 STAT1 Head and neck squamous cell carcinoma Phosphorylation N S710 P42224 6772 STAT1 Immunodeficiency Phosphorylation N S710 P42224 6772 STAT1 Lung adenocarcinoma Phosphorylation N S710 P42224 6772 STAT1 Inherited immunodeficiency diseases Phosphorylation N S715 P42224 6772 STAT1 Lung adenocarcinoma Phosphorylation N S715 P42224 6772 STAT1 Bladder urothelial carcinoma Phosphorylation N S727 P42224 6772 STAT1 Inherited immunodeficiency diseases Phosphorylation N S727 P42224 6772 STAT1 Ovarian cancer Phosphorylation N S735 P42224 6772 STAT1 Bladder urothelial carcinoma Phosphorylation N S740 P42224 6772 STAT1 Head and neck squamous cell carcinoma Phosphorylation N S740 P42224 6772 STAT1 Head and neck squamous cell carcinoma Phosphorylation N S745 P42224 6772 STAT1 Head and neck squamous cell carcinoma Phosphorylation N T749 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Colorectal cancer Phosphorylation N S13 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung cancer Phosphorylation N S13 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Hepatocellular carcinoma Phosphorylation N S63 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Stomach adenocarcinoma Phosphorylation N S63 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma Methylation N R83 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Skin cutaneous melanoma Methylation N R83 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Adrenocortical carcinoma Ubiquitination N K91 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Adrenocortical carcinoma Phosphorylation N S95 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Malignant glioma Phosphorylation N S101 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Ovarian adenocarcinoma Acetylation N K116 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Stomach adenocarcinoma Acetylation N K116 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Skin cutaneous melanoma Phosphorylation N T140 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Bladder urothelial carcinoma Ubiquitination N K157 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Breast invasive carcinoma Ubiquitination N K157 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Hepatocellular carcinoma Ubiquitination N K157 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Immunodeficiency Ubiquitination N K157 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Inherited immunodeficiency diseases Ubiquitination N K157 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung squamous cell carcinoma Ubiquitination N K157 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Bladder urothelial carcinoma Ubiquitination N K165 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Breast invasive carcinoma Ubiquitination N K165 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Immunodeficiency Ubiquitination N K165 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Inherited immunodeficiency diseases Ubiquitination N K165 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma Ubiquitination N K165 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Melanoma Ubiquitination N K165 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Melanoma Phosphorylation C S168 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Bladder urothelial carcinoma Phosphorylation N S168 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Breast invasive carcinoma Phosphorylation N S168 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Immunodeficiency Phosphorylation N S168 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Inherited immunodeficiency diseases Phosphorylation N S168 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma Phosphorylation N S168 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Breast invasive carcinoma Acetylation N K171 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Immunodeficiency Acetylation N K171 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma Acetylation N K171 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Melanoma Acetylation N K171 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Breast invasive carcinoma SUMOylation N K171 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma SUMOylation N K171 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Melanoma SUMOylation N K171 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Breast invasive carcinoma Ubiquitination N K171 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma Ubiquitination N K171 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Melanoma Ubiquitination N K171 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Breast invasive carcinoma Ubiquitination N K174 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Melanoma Ubiquitination N K174 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Brain lower grade glioma Phosphorylation N S214 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Hepatocellular carcinoma Phosphorylation N S214 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Immunodeficiency Phosphorylation N S214 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Brain lower grade glioma Phosphorylation N S215 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Hepatocellular carcinoma Phosphorylation N S215 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Immunodeficiency Phosphorylation N S215 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Colon adenocarcinoma Ubiquitination N K220 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Hepatocellular carcinoma Ubiquitination N K220 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Skin cutaneous melanoma Ubiquitination N K220 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Colon adenocarcinoma SUMOylation N K241 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma SUMOylation N K241 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Colon adenocarcinoma Ubiquitination N K241 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma Ubiquitination N K241 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma Ubiquitination N K255 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma Phosphorylation N S258 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Colorectal cancer Phosphorylation N S261 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma Phosphorylation N S261 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Uterine cancer Phosphorylation N S261 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S269 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Uterine corpus endometrial carcinoma Phosphorylation N S269 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K273 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Skin cutaneous melanoma Ubiquitination N K273 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Uterine corpus endometrial carcinoma Ubiquitination N K273 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma Ubiquitination N K281 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Melanoma Ubiquitination N K281 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Skin cutaneous melanoma Ubiquitination N K281 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma Ubiquitination N K286 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Melanoma Ubiquitination N K286 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Skin cutaneous melanoma Ubiquitination N K286 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma Phosphorylation N S289 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Melanoma Phosphorylation N S289 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Skin cutaneous melanoma Phosphorylation N S289 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma Phosphorylation N S295 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung adenocarcinoma Phosphorylation N S296 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Bladder urothelial carcinoma Phosphorylation N S298 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Prostate cancer Phosphorylation N S298 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Skin cutaneous melanoma Phosphorylation N S298 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Bladder urothelial carcinoma Ubiquitination N K301 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Skin cutaneous melanoma Ubiquitination N K301 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Head and neck squamous cell carcinoma Phosphorylation N T333 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Hepatocellular carcinoma Phosphorylation N T333 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N T358 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S361 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Esophageal cancer Phosphorylation N S361 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S364 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Sarcoma Phosphorylation N S364 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Stomach cancer Phosphorylation N S364 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Sarcoma Phosphorylation N S368 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Kidney renal clear cell carcinoma Phosphorylation N S377 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Kidney renal clear cell carcinoma Ubiquitination N K378 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Breast invasive carcinoma Ubiquitination N K380 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Kidney renal clear cell carcinoma Ubiquitination N K380 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Breast invasive carcinoma Phosphorylation N S389 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Kidney renal clear cell carcinoma Phosphorylation N S389 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Breast invasive carcinoma Phosphorylation N S391 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Kidney renal clear cell carcinoma Phosphorylation N S391 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Breast invasive carcinoma Phosphorylation N S393 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Prostate adenocarcinoma Phosphorylation N S393 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Prostate cancer Phosphorylation N S393 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Skin cutaneous melanoma Phosphorylation N S393 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Uterine cancer Phosphorylation N S402 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Skin cutaneous melanoma Phosphorylation N S409 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Glioblastoma multiforme Phosphorylation C S427 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Stomach adenocarcinoma Phosphorylation C S427 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung squamous cell carcinoma Phosphorylation N S427 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Melanoma Phosphorylation N S427 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Skin cutaneous melanoma Phosphorylation N S427 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Glioblastoma multiforme SUMOylation N K429 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung squamous cell carcinoma SUMOylation N K429 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Skin cutaneous melanoma SUMOylation N K429 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Stomach adenocarcinoma SUMOylation N K429 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Glioblastoma multiforme Ubiquitination N K429 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Lung squamous cell carcinoma Ubiquitination N K429 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Skin cutaneous melanoma Ubiquitination N K429 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Stomach adenocarcinoma Ubiquitination N K429 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S442 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Head and neck squamous cell carcinoma Phosphorylation N S442 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Stomach adenocarcinoma Phosphorylation N S442 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Breast invasive carcinoma Phosphorylation N S445 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S445 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Head and neck squamous cell carcinoma Phosphorylation N S445 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Stomach adenocarcinoma Phosphorylation N S445 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Inherited immunodeficiency diseases Ubiquitination N K460 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Uterine corpus endometrial carcinoma Ubiquitination N K460 P40763 6774 STAT3 APRF Pancreatic cancer tumor tissue Phosphorylation U 37443111 P40763 6774 STAT3 APRF Non-small cell lung cancer tumor tissue Deubiquitination U 30881015 P42224 6772 STAT1 Glioma glioma tissues Acetylation U 34784299 P40763 6774 STAT3 APRF Hepatocellular carcinoma HCC tissues Acetylation U 37792308 P40763 6774 STAT3 APRF Oral squamous cell carcinoma tumor tissue Phosphorylation U 35562900 P40763 6774 STAT3 APRF Triple-negative breast cancer tumor tissue Phosphorylation U 37095176 P40763 6774 STAT3 APRF Gastric cancer tumor tissue Phosphorylation U 36769245 P40763 6774 STAT3 APRF Psoriasis epidermal keratinocytes Phosphorylation U 28901004 P40763 6774 STAT3 APRF Triple-negative breast cancer tumor tissue Phosphorylation U 34408002 P40763 6774 STAT3 APRF Colorectal cancer tumor tissue Phosphorylation U 33982216 P40763 6774 STAT3 APRF Pancreatic cancer tumor tissue Deubiquitination U 33123271 P42224 6772 STAT1 Diffuse large B-cell lymphoma tumor tissue Mono(ADP-ribosyl)ation U 23487038 P40763 6774 STAT3 APRF Retinoblastoma tumor tissue Ubiquitination P 35980647 P40763 6774 STAT3 APRF Breast cancer tumor tissue Deacetylation D 30365149 P40763 6774 STAT3 APRF Renal cell carcinoma RCC tissues Deacetylation A 31201813 P40763 6774 STAT3 APRF Glioblastoma tumor tissue Lysine methylation U K180 29076964 P40763 6774 STAT3 APRF Prostate cancer tumor tissue Threonine phosphorylation D T622 35722967 P40763 6774 STAT3 APRF Triple-negative breast cancer breast tumor tissues Lysine methylation U K685 29487338 P40763 6774 STAT3 APRF Colorectal cancer tumor tissue Tyrosine phosphorylation U Y705 36266267 P40763 6774 STAT3 APRF Glioblastoma glioblastoma tissue Tyrosine phosphorylation U Y705 34411567;20455003 P40763 6774 STAT3 APRF Melanoma tumor tissue Tyrosine phosphorylation U Y705 35184394;22899991 P40763 6774 STAT3 APRF Multiple myeloma tumor tissue Tyrosine phosphorylation U Y705 34782371 P40763 6774 STAT3 APRF Pancreatic cancer pancreatic cancer cells Tyrosine phosphorylation U Y705 37548811;36374556 P40763 6774 STAT3 APRF Triple-negative breast cancer breast tumor tissues Tyrosine phosphorylation U Y705 34066153;35091679 P40763 6774 STAT3 APRF Breast cancer BRCA tissues Dimethylation U R729 37813837 P42224 6772 STAT1 Arterial lesions haematopoietic cells Mono(ADP-ribosyl)ation D E657 27796300 P42224 6772 STAT1 Arterial lesions haematopoietic cells Mono(ADP-ribosyl)ation D E705 27796300 P42224 6772 STAT1 Chronic colitis Phosphorylation U 37211384 P40763 6774 STAT3 APRF Chronic lymphocytic leukemia Acetylation U K685 30263097 P40763 6774 STAT3 APRF B-cell acute lymphoblastic leukemia Serine phosphorylation U S727 33393494 P40763 6774 STAT3 APRF Small cell lung cancer/carcinoma tumor tissue Phosphorylation U 22938476 P40763 6774 STAT3 APRF Precancerous lesion of gastric cancer tumor tissue Phosphorylation U 23596790 P40763 6774 STAT3 APRF Colon cancer/carcinoma tumor tissue Phosphorylation P 23335526 P40763 6774 STAT3 APRF Liver cancer tumor tissue Phosphorylation P 23460367 P42224 6772 STAT1 Epidermoid carcinoma A431 cell line Phosphorylation P 23178573 P42224 6772 STAT1 Esophageal carcinoma tumor tissue Polyubiquitination D 30506884 P40763 6774 STAT3 APRF Ulcerative colitis colonic tissues Palmitoylation U 38150914 P40763 6774 STAT3 APRF Osteosarcoma OS cells Phosphorylation U 32549792 P40763 6774 STAT3 APRF Hepatocellular carcinoma tumor tissue Phosphorylation U 37178251 P40763 6774 STAT3 APRF Gastric cancer SGC-7901 Phosphorylation U 35087591 P40763 6774 STAT3 APRF Non-small cell lung cancer TAM/M2 Phosphorylation U 36372977 P40763 6774 STAT3 APRF Cancer tumor tissue Acetylation A K685 38000524 P40763 6774 STAT3 APRF Bladder cancer bladder cancer tissues Phosphorylation U Y705 34326684 P40763 6774 STAT3 APRF Bladder cancer bladder cancer cells Tyrosine phosphorylation N Y705 18939995 P40763 6774 STAT3 APRF Breast cancer/tumor/carcinoma breast cancer cell lines Tyrosine phosphorylation P Y705 23350355;22374428;23446809 P40763 6774 STAT3 APRF Colon cancer/carcinoma CRC cells Tyrosine phosphorylation P Y705 22754353;21840932 P40763 6774 STAT3 APRF Breast cancer/tumor/carcinoma tumor tissue Tyrosine phosphorylation U Y705 24707243 P40763 6774 STAT3 APRF Cancer cell line Tyrosine phosphorylation U Y705 23145121 P40763 6774 STAT3 APRF Colon adenocarcinoma COAD tissues Tyrosine phosphorylation U Y705 34270850 P40763 6774 STAT3 APRF Esophageal squamous cell carcinoma ESCC cell lines Tyrosine phosphorylation U Y705 23676499 P40763 6774 STAT3 APRF Pancreatic cancer/carcinoma/adenocarcinoma pancreatic cancer cells Tyrosine phosphorylation U Y705 18519681 P40763 6774 STAT3 APRF Prostate cancer/carcinoma/adenocarcinoma tumor tissue Tyrosine phosphorylation U Y705 22307624;19147545 P40763 6774 STAT3 APRF Renal cancer/carcinoma renal carcinoma Caki cells Tyrosine phosphorylation U Y705 22982675 P40763 6774 STAT3 APRF Renal cell carcinoma cell line Tyrosine phosphorylation U Y705 22899991 P40763 6774 STAT3 APRF Pancreatic cancer pancreatic cancer cells Serine phosphorylation D S727 37548811 P40763 6774 STAT3 APRF Pancreatic cancer/carcinoma/adenocarcinoma cell lines Serine phosphorylation D S727 18519681 P40763 6774 STAT3 APRF Breast cancer/tumor/carcinoma cell line Serine phosphorylation P S727 23329648;23329839 P40763 6774 STAT3 APRF Cancer cell line Serine phosphorylation P S727 23145121 P40763 6774 STAT3 APRF Melanoma melanoma cells Serine phosphorylation P S727 22418867 P40763 6774 STAT3 APRF Hepatocellular carcinoma HCC cells Serine phosphorylation U S727 31498440 P40763 6774 STAT3 APRF Thyroid cancer/carcinoma tumor tissue Serine phosphorylation U S727 17209045 P42224 6772 STAT1 Melanoma melanoma cell lines Tyrosine phosphorylation D Y701 17785551 P40763 6774 STAT3 APRF Neuroblastoma Phosphorylation U 15715521 P40763 6774 STAT3 APRF Bladder cancer Phosphorylation U 15034568 P40763 6774 STAT3 APRF Glioblastoma Phosphorylation C 24135280 P40763 6774 STAT3 APRF Prostate cancer/carcinoma/adenocarcinoma Phosphorylation U 10853013 P40763 6774 STAT3 APRF Breast cancer/tumor/carcinoma Phosphorylation U 10853013 P40763 6774 STAT3 APRF Ulcerative colitis Phosphorylation U 11181699 P40763 6774 STAT3 APRF Crohn's disease Phosphorylation U 11181699 P40763 6774 STAT3 APRF Colitis Phosphorylation U 11181699 P42224 6772 STAT1 Melanoma Phosphorylation D 12421984 P42224 6772 STAT1 Lymphoma Phosphorylation D 12421984 P40763 6774 STAT3 APRF Bladder cancer Phosphorylation U 23526079 P40763 6774 STAT3 APRF Gastric cancer Phosphorylation U 24116074 P40763 6774 STAT3 APRF Endometrial cancer/carcinoma Phosphorylation U 24321270 P42224 6772 STAT1 Chronic lymphocytic leukemia Phosphorylation U 23936412 P42224 6772 STAT1 Oral squamous cell carcinoma Phosphorylation P 23992782 P40763 6774 STAT3 APRF Pancreatic cancer/carcinoma/adenocarcinoma Phosphorylation P 24132924 P40763 6774 STAT3 APRF Skin cancer Phosphorylation P 24460316 P40763 6774 STAT3 APRF Ovarian cancer/carcinoma Phosphorylation P 15010843 P42224 6772 STAT1 Neuroblastoma Phosphorylation P 14982729 P40763 6774 STAT3 APRF Sarcoma Phosphorylation P 15010843 O14746 7015 TERT EST2 TCS1 TRT Liver cancer Threonine phosphorylation U T249 35094384 O14746 7015 TERT EST2 TCS1 TRT Lung cancer Threonine phosphorylation U T249 35094384 O14746 7015 TERT EST2 TCS1 TRT Pancreatic cancer Threonine phosphorylation U T249 35094384 O60832 1736 DKC1 NOLA4 X-linked dyskeratosis congenita SUMOylation N K39 23660516 P40763 6774 STAT3 APRF Glioblastoma Lysine methylation P K180 23684459 P40763 6774 STAT3 APRF Chronic myelogenous leukemia/chronic myeloid leukemia Phosphorylation N Y640 23872306 P40763 6774 STAT3 APRF Lymphoma Acetylation U K685 27582487 P40763 6774 STAT3 APRF Prostate cancer Acetylation U K685 28489571 P40763 6774 STAT3 APRF Triple-negative breast cancer Acetylation U K685 29137356 P40763 6774 STAT3 APRF Nasopharyngeal carcinoma Dephosphorylation U Y705 33824475 P40763 6774 STAT3 APRF Inflammatory disease Tyrosine phosphorylation D Y705 24063605 P40763 6774 STAT3 APRF Triple-negative breast cancer Tyrosine phosphorylation D Y705 36017196 P40763 6774 STAT3 APRF Acute myelogenous leukemia Tyrosine phosphorylation U Y705 34525179 P40763 6774 STAT3 APRF B-cell lymphoma Tyrosine phosphorylation U Y705 22116549 P40763 6774 STAT3 APRF Breast cancer Tyrosine phosphorylation U Y705 17967179;17967179;18353781;35927628 P40763 6774 STAT3 APRF Clear cell kidney cancer Tyrosine phosphorylation U Y705 24615012 P40763 6774 STAT3 APRF Esophageal carcinoma Tyrosine phosphorylation U Y705 33986510 P40763 6774 STAT3 APRF Experimental autoimmune encephalomyelitis Tyrosine phosphorylation U Y705 32094172 P40763 6774 STAT3 APRF Fibrosarcoma Tyrosine phosphorylation U Y705 21575192 P40763 6774 STAT3 APRF Glioblastoma multiforme Tyrosine phosphorylation U Y705 35670018 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Tyrosine phosphorylation U Y705 21281788 P40763 6774 STAT3 APRF Hepatocellular carcinoma Tyrosine phosphorylation U Y705 22153071 P40763 6774 STAT3 APRF Hepatocellular carcinoma/hepatocarcinoma/hepatoma Tyrosine phosphorylation U Y705 21311975 P40763 6774 STAT3 APRF Laryngeal cancer Tyrosine phosphorylation U Y705 27181202 P40763 6774 STAT3 APRF Lung cancer Tyrosine phosphorylation U Y705 34543857 P40763 6774 STAT3 APRF Malignant gliomas Tyrosine phosphorylation U Y705 23740516 P40763 6774 STAT3 APRF Multiple sclerosis Tyrosine phosphorylation U Y705 32094172 P40763 6774 STAT3 APRF Myeloma Tyrosine phosphorylation U Y705 22210382 P40763 6774 STAT3 APRF Neurofibromatosis Tyrosine phosphorylation U Y705 23318430 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Tyrosine phosphorylation U Y705 30054295 P40763 6774 STAT3 APRF Prostate cancer Tyrosine phosphorylation U Y705 19147545;19147545 P40763 6774 STAT3 APRF T-cell lymphoma Tyrosine phosphorylation U Y705 35882439 P40763 6774 STAT3 APRF Clear cell kidney cancer Threonine phosphorylation U T714 24615012 P40763 6774 STAT3 APRF Oral squamous epithelial carcinoma Serine phosphorylation D S727 23733313 P40763 6774 STAT3 APRF Triple-negative breast cancer Serine phosphorylation D S727 36017196 P40763 6774 STAT3 APRF Prostate cancer/carcinoma/adenocarcinoma Serine phosphorylation P S727 23941877 P40763 6774 STAT3 APRF Chronic lymphocytic leukemia Serine phosphorylation U S727 35595309 P40763 6774 STAT3 APRF Clear cell kidney cancer Serine phosphorylation U S727 24615012;33772065;37945711 P40763 6774 STAT3 APRF Glioblastoma multiforme Serine phosphorylation U S727 35670018 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Serine phosphorylation U S727 21281788 P40763 6774 STAT3 APRF Prostate cancer Serine phosphorylation U S727 18829527 P42224 6772 STAT1 Chronic mucocutaneous candidiasis disease Phosphorylation N R274 21727188 P42224 6772 STAT1 Chronic mucocutaneous candidiasis Threonine phosphorylation N T387 33096415 P42224 6772 STAT1 Breast cancer/tumor/carcinoma Tyrosine phosphorylation U Y701 24058806 P42224 6772 STAT1 Secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome Tyrosine phosphorylation U Y701 33815425 P42224 6772 STAT1 Colorectal cancer Serine phosphorylation U S727 33747209 P42224 6772 STAT1 Nephroblastoma Serine phosphorylation U S727 16799645 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 B-cell acute lymphoblastic leukemia SUMOylation U K58 27315244 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 B-cell acute lymphoblastic leukemia SUMOylation U K240 27315244 Q13422 10320 IKZF1 IK1 IKAROS LYF1 ZNFN1A1 B-cell acute lymphoblastic leukemia SUMOylation U K425 27315244